|
covid-19 |
2 |
|
diagnosis |
2 |
|
inflatable penile prosthesis |
2 |
|
penile cancer |
2 |
|
squamous cell carcinoma |
2 |
|
telemedicine |
2 |
|
|
1 |
|
|
1 |
|
|
1 |
|
accuracy |
1 |
|
acontractile detrusor |
1 |
|
active surveillance |
1 |
|
active surveillance and monitoring |
1 |
|
acute renal colic |
1 |
|
acute urology |
1 |
|
adjuncts |
1 |
|
autism |
1 |
|
autistic spectrum disorder |
1 |
|
bcg vaccine |
1 |
|
benign prostate enlargement |
1 |
|
biochemical and clinical outcomes |
1 |
|
biomarker |
1 |
|
bladder |
1 |
|
bladder cancer |
1 |
|
bladder neoplasm |
1 |
|
bladder outlet obstruction |
1 |
|
boot camp |
1 |
|
bpe |
1 |
|
brachytherapy |
1 |
|
branchial arches |
1 |
|
brief male sexual function inventory |
1 |
|
bronchogenic cyst |
1 |
|
cancer |
1 |
|
centralisation |
1 |
|
chemotherapy |
1 |
|
chronic venous ulcers |
1 |
|
circumcision |
1 |
|
clinical practice guidelines |
1 |
|
clinical practice guidelines and recommendations |
1 |
|
clinical protocols |
1 |
|
complications |
1 |
|
consensus group meeting |
1 |
|
consensus statements |
1 |
|
constipation |
1 |
|
consultant practice |
1 |
|
core involvement |
1 |
|
covid-19 [supplementary concept] |
1 |
|
covid-19 diagnostic testing [supplementary concept] |
1 |
|
covid-19; urology; oncology service |
1 |
|
criteria for inclusion and eligibility |
1 |
|
cystoscopy |
1 |
|
deferred treatment with curative intent |
1 |
|
delphi survey |
1 |
|
detrusor underactivity |
1 |
|
drug therapy |
1 |
|
education |
1 |
|
eep |
1 |
|
ejaculatory function |
1 |
|
electronic tablet |
1 |
|
eligibility |
1 |
|
embolization |
1 |
|
emergency department |
1 |
|
endourology |
1 |
|
enhanced recovery after surgery |
1 |
|
enucleation |
1 |
|
environment |
1 |
|
epidemiology |
1 |
|
epigenetics |
1 |
|
eras |
1 |
|
erectile dysfunction |
1 |
|
erectile function |
1 |
|
ethics |
1 |
|
europe |
1 |
|
european association of urology guidelines |
1 |
|
extracorporeal shockwave lithotripsy |
1 |
|
female |
1 |
|
follow-up |
1 |
|
foundation programme |
1 |
|
foundation school |
1 |
|
frozen section examination |
1 |
|
gender affirmation surgery |
1 |
|
genetic variance |
1 |
|
getting published |
1 |
|
glans resurfacing |
1 |
|
glansectomy |
1 |
|
healing rates |
1 |
|
holep |
1 |
|
holmium |
1 |
|
hospital; surgical procedures |
1 |
|
immediate radical cystectomy |
1 |
|
immunotherapy |
1 |
|
impact of delay |
1 |
|
infertility |
1 |
|
international index of erectile function |
1 |
|
intravesical therapy |
1 |
|
ipp |
1 |
|
iscp |
1 |
|
laparoscopic |
1 |
|
laparoscopic ureteric reimplantation |
1 |
|
laser |
1 |
|
laser ablation |
1 |
|
lithiasis |
1 |
|
localised prostate cancer |
1 |
|
location |
1 |
|
location of training |
1 |
|
lower urinary tract symptoms |
1 |
|
lymphadenectomy |
1 |
|
male sexual health questionnaire |
1 |
|
malleable penile prosthesis |
1 |
|
manuscript preparation |
1 |
|
margins |
1 |
|
medical students |
1 |
|
melanoma |
1 |
|
mental health |
1 |
|
meta-analysis |
1 |
|
microsurgical |
1 |
|
midline cervical cleft |
1 |
|
minimally invasive |
1 |
|
minimally invasive surgical procedures |
1 |
|
mitomycin c |
1 |
|
mohs micrography |
1 |
|
monitoring and reclassification |
1 |
|
neoadjuvant chemotherapy |
1 |
|
neophallus |
1 |
|
neoplasm grading |
1 |
|
neurogenic |
1 |
|
neurogenic erectile dysfunction |
1 |
|
next-generation sequencing (ngs) |
1 |
|
non-muscle invasive bladder cancer (nmibc) |
1 |
|
occupational exposure |
1 |
|
oncological outcomes |
1 |
|
one-lobe |
1 |
|
operative; telemedicine |
1 |
|
other |
1 |
|
outcome measures |
1 |
|
patient information leaflets |
1 |
|
pelvic lymph node dissection |
1 |
|
penile prosthesis |
1 |
|
penile-preserving surgery |
1 |
|
per-protocol or untriggered repeat biopsies |
1 |
|
phalloplasty |
1 |
|
polygenic risk score |
1 |
|
positive cores |
1 |
|
primary cystectomy |
1 |
|
prostate cancer risk |
1 |
|
prostatic neoplasms |
1 |
|
publication |
1 |
|
publication pressure |
1 |
|
quality of life |
1 |
|
radiation therapy |
1 |
|
radical cystectomy |
1 |
|
radical orchidectomy |
1 |
|
radical radiotherapy |
1 |
|
radiotherapy |
1 |
|
reclassification |
1 |
|
reconstruction |
1 |
|
recurrence rates |
1 |
|
relapse |
1 |
|
renal coli |
1 |
|
residency costs |
1 |
|
residents |
1 |
|
robotic |
1 |
|
robotics |
1 |
|
salary |
1 |
|
sarcomatoid |
1 |
|
service provision |
1 |
|
sexual function |
1 |
|
sexual health |
1 |
|
sexual health inventory men |
1 |
|
simulation |
1 |
|
single-nucleotide polymorphism |
1 |
|
slow transit constipation |
1 |
|
small testicular masses |
1 |
|
smart learning |
1 |
|
social relationships |
1 |
|
solitary kidney |
1 |
|
spinal cord injury |
1 |
|
sponsorship |
1 |
|
steroid |
1 |
|
surveillance |
1 |
|
survey |
1 |
|
survival |
1 |
|
survival outcomes |
1 |
|
systematic review |
1 |
|
test |
1 |
|
testicular biopsy |
1 |
|
testicular cancer |
1 |
|
testosterone replacement treatment |
1 |
|
thulep |
1 |
|
thulium |
1 |
|
trainees |
1 |
|
training |
1 |
|
training costs |
1 |
|
treatment |
1 |
|
triamcinolone |
1 |
|
two-lobe |
1 |
|
uk postgraduate training |
1 |
|
ultrasound-guided foam sclerotherapy |
1 |
|
underactive bladder |
1 |
|
ureteral stricture |
1 |
|
ureteric stone |
1 |
|
urethral dilatation |
1 |
|
urethral recurrence |
1 |
|
urethral stricture |
1 |
|
urethral surveillance |
1 |
|
urethrectomy |
1 |
|
urethroplasty |
1 |
|
urethroscopy |
1 |
|
urethrotomy |
1 |
|
urinary biomarkers |
1 |
|
urinary bladder neoplasms |
1 |
|
urinary diversion |
1 |
|
urodynamics |
1 |
|
urogenital cancer |
1 |
|
urolithiasis |
1 |
|
urology |
1 |
|
urology residents |
1 |
|
urothelial |
1 |
|
urothelial cancer |
1 |
|
urothelial cell carcinoma |
1 |
|
varicocele |
1 |
|
well-being |
1 |
|
wide local excision |
1 |
|
writing |
1 |
